印度藏茴香植物精油对温室棉蚜的熏蒸毒性及其成分分析（英文）

【目的】棉蚜Aphis gossypii是世界各地室内和室外果树、蔬菜和观赏植物上最具危害性的害虫之一。这一害虫取食植物汁液,产生蜜露,传播植物病毒,对植物从质和量上产生破坏。为了控制温室中的这一害虫,植物精油可用作化学农药的替代药物。本实验研究了印度藏茴香Carum copticum植物精油对棉蚜成虫的熏蒸毒性。【方法】将研磨的印度藏茴香干种子用改良的挥发油提取器(Clevenger-type apparatus)进行水蒸馏。所有生物测定均在27±2℃,相对湿度65%±5%和光周期16L∶8D条件下进行。研究采用完全随机设计,6个处理(5个不同浓度的精油加对照)。每一浓度3次重复,每一重复20头成虫。【结果】结果表明,棉蚜成蚜接触印度藏茴香精油24 h后出现明显的死亡。该精油对棉蚜成蚜的致死中浓度(LC50)为1.21μL/L空气。棉蚜成蚜的死亡百分率对精油的施用表现出较高的敏感性。精油浓度为1.21μL/L空气时,估计的棉蚜的致死中时(LT50)为11.79 h。这一精油的熏蒸毒性与浓度和接触时间之间具有一定的相关性。GC/MS组分分析结果表明,该精油由18种化合物组成,最重要的是一些化合物引起了熏蒸毒性,如麝香草酚(占50.07%)、γ-萜品烯(占23.99%)和对异丙基苯甲烷(占22.90%)。【结论】本研究结果表明印度藏茴香植物精油对棉蚜具有较好的杀虫效果。印度藏茴香精油对棉蚜产生较大的影响,由于它具有较高的熏蒸毒性潜力,因此可在温室中用于这一害虫的综合治理。     

Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes

Chamomile extracts and tea are widely used herbal preparations for the treatment of minor illnesses (e.g. indigestion, inflammation). In this study the inhibitory effect of chamomile essential oil and its major constituents on four selected human cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP2D6 and CYP3A4) was investigated. Increasing concentrations of the test compounds were incubated with individual, recombinant CYP isoforms and their effect on the conversion of surrogate substances was measured fluorometrically in 96-well plates; enzyme inhibition was expressed as IC50 and Ki value in relation to positive controls. Crude essential oil demonstrated inhibition of each of the enzymes, with CYP1A2 being more sensitive than the other isoforms. Three constituents of the oil, namely chamazulene (IC50 = 4.41 microM), cis-spiroether (IC50 = 2.01 microM) and trans-spiroether (IC50 = 0.47 microM) showed to be potent inhibitors of this enzyme, also being active towards CYP3A4. CYP2C9 and CYP2D6 were less inhibited, only chamazulene (IC50 = 1.06 microM) and alpha-bisabolol (IC50 = 2.18 microM) revealed a significant inhibition of the latter. As indicated by these in vitro data, chamomile preparations contain constituents inhibiting the activities of major human drug metabolizing enzymes; interactions with drugs whose route of elimination is mainly via cytochromes (especially CYP1A2) are therefore possible.